Philippe P Roux

Molecular Biology · 2002–2011

A researcher in the Science corpus: 7 papers; trusts 7 researchers and is trusted by 17 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 93 citations into it; #2,285 of 17,773 by trust here, #2,535 by citations
• Oncology — 16 citations into it
• Cell Biology — 14 citations into it; #947 of 2,073 by trust here, #1,656 by citations

Whom Philippe P Roux trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Kyriakis
2. J. Avruch
3. A. Newton
4. M. Karin
5. Julian Downward
6. J. Blenis
7. K. Inoki
8. D. Fingar

Who trusts Philippe P Roux overall

1. R. Anjum
2. Young Chul Kim
3. David M. Sabatini
4. M. Laplante
5. J. Blenis
6. K. Guan
7. M. Chao
8. Arkaitz Carracedo
9. R. A. Saxton
10. M. Bahar

Papers from Philippe P Roux's perspective

Ordered by how strongly the researchers Philippe P Roux trusts endorse each paper. Same corpus, a different order for every researcher.

1. TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
2. TOR signaling in growth and metabolism. (Cell)
3. The selectivity of protein kinase inhibitors: a further update. (Biochemical Journal)
4. Differential regulation and properties of MAPKs (Oncogene)
5. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (Molecules and Cells)
6. Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
7. S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway (Molecular and Cellular Biology)
8. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. (Cancer Cell)
9. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
10. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. (Biochemical Journal)

Their papers

• Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. (2004) — 797 citations
• Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. (2003) — 1,260 citations
• Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation (2008) — 856 citations
• RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* (2007) — 763 citations
• ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions (2004) — 2,565 citations
• Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases (2011) — 2,966 citations
• Neurotrophin signaling through the p75 neurotrophin receptor. (2002) — 751 citations